Maria Carla Roncaglioni
Overview
Explore the profile of Maria Carla Roncaglioni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
2302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baviera M, Foresta A, Fernandez L, Torrigiani G, Tettamanti M, Roncaglioni M, et al.
Intern Emerg Med
. 2024 Sep;
20(1):159-169.
PMID: 39347889
Peripheral artery disease (PAD) remains underdiagnosed in patients with coronary artery disease (CAD) and barriers persist to measure screening PAD in routine clinical practice. We assessed the prevalence of PAD...
2.
Foresta A, Fernandez L, Torrigiani G, Schena S, Roncaglioni M, Nobili A, et al.
Drugs Aging
. 2024 Feb;
41(3):239-249.
PMID: 38367169
Background: The unfavorable effect of proton pump inhibitors (PPIs) on cardiovascular (CV) outcomes and mortality was reported in the general population. We investigated the impact of PPIs on CV outcomes...
3.
Foresta A, Ojeda-Fernandez L, Augurio C, Guanziroli C, Tettamanti M, Macaluso G, et al.
J Prim Care Community Health
. 2024 Jan;
15:21501319231222364.
PMID: 38166461
Background: Despite all the progress in the management of acute COVID-19, it is still not clear why some people continue to experience symptoms after recovery. Using data from a self-administered...
4.
Ojeda-Fernandez L, Baviera M, Foresta A, Tettamanti M, Zambon A, Macaluso G, et al.
Front Cardiovasc Med
. 2023 Oct;
10:1244002.
PMID: 37781303
Background: COVID-19 has been associated with a higher risk of post-acute complications. Our aim was to analyze and compare post-acute cardiovascular complications of COVID-19 survivors of the first and second/third...
5.
Di Castelnuovo A, Bonaccio M, Costanzo S, De Curtis A, Persichillo M, Panzera T, et al.
Int J Cardiol
. 2023 Aug;
389:131228.
PMID: 37527754
Background: Cardiovascular (CV) disease is preventable through interventions targeting modifiable factors. Most algorithms based on modifiable CV risk factors (CV-rf) have been developed in US populations and do not account...
6.
Baldassarre D, Iacoviello L, Baetta R, Roncaglioni M, Condorelli G, Remuzzi G, et al.
BMJ Open
. 2023 Jul;
13(7):e072040.
PMID: 37451717
Introduction: Prevention of cardiovascular disease (CVD) is of key importance in reducing morbidity, disability and mortality worldwide. Observational studies suggest that digital health interventions can be an effective strategy to...
7.
Foresta A, Succurro E, Baviera M, Macaluso G, Ojeda-Fernandez L, Roncaglioni M, et al.
Diabetes Res Clin Pract
. 2023 Jun;
202:110742.
PMID: 37270072
Aims: To describe glucose-lowering drugs prescribing pattern in a large population of older diabetics from 2010 to 2021. Methods: Using linkable administrative health databases, we included patients aged 65-90 years...
8.
Foresta A, Ojeda-Fernandez L, Macaluso G, Roncaglioni M, Tettamanti M, Fortino I, et al.
Clin Ther
. 2023 Mar;
45(4):e115-e126.
PMID: 36933975
Purpose: It has been reported that dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1 RA), and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have a role in modulation of inflammation associated with...
9.
Trombara F, Cosentino N, Bonomi A, Ludergnani M, Poggio P, Gionti L, et al.
Cardiovasc Diabetol
. 2023 Feb;
22(1):26.
PMID: 36747186
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection. Whether their benefits occur also during hospitalization for acute myocardial infarction (AMI)...
10.
Baviera M, Genovese S, Colacioppo P, Cosentino N, Foresta A, Tettamanti M, et al.
Cardiovasc Diabetol
. 2022 Oct;
21(1):223.
PMID: 36309742
Background: Diabetes mellitus (DM) is associated with an increased mortality risk in patients hospitalized with acute myocardial infarction (AMI); however, no studies have investigated the impact of the duration of...